Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients
- 30 June 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (6) , 951-959
- https://doi.org/10.1016/s0168-8278(98)80342-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response ratesJournal of Hepatology, 1995
- Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in Western EuropeJournal of Medical Virology, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- Reliability of polymerase chain reaction for detection of hepatitis C virusThe Lancet, 1993
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977